Meyka Pro banner
The Joint Corp.

The Joint Corp. Fundamental Analysis (NASDAQ: JYNT)

JYNT●NASDAQ
HealthcareMedical - Care Facilities
$6.83
$0.18(2.71%)
U.S. Market opens in 1h 12m

The Joint Corp. Fundamental Analysis (NASDAQ: JYNT)

The Joint Corp. (NASDAQ: JYNT) shows moderate financial fundamentals with a PE ratio of 33.98, profit margin of 7.49%, and ROE of 30.02%. The company generates $0.1B in annual revenue with moderate year-over-year growth of 5.24%.

Key Strengths

ROE30.02%
Cash Position19.10%
PEG Ratio0.08
Current Ratio1.96

Areas of Concern

Operating Margin4.43%
We analyze JYNT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 59.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
59.3/100

We analyze JYNT's fundamental strength across five key dimensions:

Efficiency Score

Excellent

JYNT demonstrates superior asset utilization.

ROA > 10%
10.81%

Valuation Score

Moderate

JYNT shows balanced valuation metrics.

PE < 25
33.98
PEG Ratio < 2
0.08

Growth Score

Moderate

JYNT shows steady but slowing expansion.

Revenue Growth > 5%
5.24%
EPS Growth > 10%
1.49%

Financial Health Score

Excellent

JYNT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
1.96

Profitability Score

Moderate

JYNT maintains healthy but balanced margins.

ROE > 15%
30.02%
Net Margin ≥ 15%
7.49%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is JYNT Expensive or Cheap?

P/E Ratio

JYNT trades at 33.98 times earnings. This suggests a premium valuation.

33.98

PEG Ratio

When adjusting for growth, JYNT's PEG of 0.08 indicates potential undervaluation.

0.08

Price to Book

The market values The Joint Corp. at 7.77 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.77

EV/EBITDA

Enterprise value stands at 23.33 times EBITDA. This signals the market has high growth expectations.

23.33

How Well Does JYNT Make Money?

Net Profit Margin

For every $100 in sales, The Joint Corp. keeps $7.49 as profit after all expenses.

7.49%

Operating Margin

Core operations generate 4.43 in profit for every $100 in revenue, before interest and taxes.

4.43%

ROE

Management delivers $30.02 in profit for every $100 of shareholder equity.

30.02%

ROA

The Joint Corp. generates $10.81 in profit for every $100 in assets, demonstrating efficient asset deployment.

10.81%

Following the Money - Real Cash Generation

Operating Cash Flow

The Joint Corp. generates limited operating cash flow of $3.51M, signaling weaker underlying cash strength.

$3.51M

Free Cash Flow

The Joint Corp. produces free cash flow of $2.28M, offering steady but limited capital for shareholder returns and expansion.

$2.28M

FCF Per Share

Each share generates $0.16 in free cash annually.

$0.16

FCF Yield

JYNT converts 2.33% of its market value into free cash.

2.33%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

33.98

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.77

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.63

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.30

vs 25 benchmark

ROA

Return on assets percentage

0.11

vs 25 benchmark

ROCE

Return on capital employed

0.11

vs 25 benchmark

How JYNT Stacks Against Its Sector Peers

MetricJYNT ValueSector AveragePerformance
P/E Ratio33.9831.47 Neutral
ROE30.02%507.00% Weak
Net Margin7.49%-4103644.00% (disorted) Weak
Debt/Equity0.160.00 Distorted
Current Ratio1.965.79 Neutral
ROA10.81%-262.00% (disorted) Strong

JYNT outperforms its industry in 1 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews The Joint Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-13.44%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-79.57%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-84.79%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ